Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Homeobox protein SIX1 (Sine oculis homeobox homolog 1)

 SIX1_MOUSE              Reviewed;         284 AA.
Q62231; Q8CIL7;
01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
13-APR-2004, sequence version 2.
31-JAN-2018, entry version 152.
RecName: Full=Homeobox protein SIX1;
AltName: Full=Sine oculis homeobox homolog 1;
Name=Six1;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA] OF 12-284.
STRAIN=C57BL/6J; TISSUE=Embryo;
PubMed=7720577;
Oliver G., Wehr R., Jenkins N.A., Copeland N.G., Cheyette B.N.R.,
Hartenstein V., Zipursky S.L., Gruss P.;
"Homeobox genes and connective tissue patterning.";
Development 121:693-705(1995).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=FVB/N; TISSUE=Salivary gland;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[3]
FUNCTION, AND INTERACTION WITH EYA2.
PubMed=11978764; DOI=10.1093/hmg/11.9.1045;
Sato S., Nakamura M., Cho D.H., Tapscott S.J., Ozaki H., Kawakami K.;
"Identification of transcriptional targets for Six5: implication for
the pathogenesis of myotonic dystrophy type 1.";
Hum. Mol. Genet. 11:1045-1058(2002).
[4]
DNA-BINDING.
PubMed=9826681; DOI=10.1073/pnas.95.24.14220;
Spitz F., Demignon J., Porteu A., Kahn A., Concordet J.P.,
Daegelen D., Maire P.;
"Expression of myogenin during embryogenesis is controlled by Six/sine
oculis homeoproteins through a conserved MEF3 binding site.";
Proc. Natl. Acad. Sci. U.S.A. 95:14220-14225(1998).
[5]
FUNCTION, AND INTERACTION WITH EYA3.
PubMed=12215533; DOI=10.1128/MCB.22.19.6759-6766.2002;
Ikeda K., Watanabe Y., Ohto H., Kawakami K.;
"Molecular interaction and synergistic activation of a promoter by
Six, Eya, and Dach proteins mediated through CREB binding protein.";
Mol. Cell. Biol. 22:6759-6766(2002).
[6]
DISRUPTION PHENOTYPE, AND FUNCTION.
PubMed=12668636; DOI=10.1242/dev.00440;
Laclef C., Hamard G., Demignon J., Souil E., Houbron C., Maire P.;
"Altered myogenesis in Six1-deficient mice.";
Development 130:2239-2252(2003).
[7]
FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
PubMed=12783782; DOI=10.1242/dev.00536;
Xu P.X., Zheng W., Huang L., Maire P., Laclef C., Silvius D.;
"Six1 is required for the early organogenesis of mammalian kidney.";
Development 130:3085-3094(2003).
[8]
DISRUPTION PHENOTYPE, AND FUNCTION.
PubMed=12834866; DOI=10.1016/S0925-4773(03)00065-0;
Laclef C., Souil E., Demignon J., Maire P.;
"Thymus, kidney and craniofacial abnormalities in Six 1 deficient
mice.";
Mech. Dev. 120:669-679(2003).
[9]
FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH DACH1 AND EYA3.
PubMed=14628042; DOI=10.1038/nature02083;
Li X., Oghi K.A., Zhang J., Krones A., Bush K.T., Glass C.K.,
Nigam S.K., Aggarwal A.K., Maas R., Rose D.W., Rosenfeld M.G.;
"Eya protein phosphatase activity regulates Six1-Dach-Eya
transcriptional effects in mammalian organogenesis.";
Nature 426:247-254(2003).
[10]
ERRATUM.
Li X., Oghi K.A., Zhang J., Krones A., Bush K.T., Glass C.K.,
Nigam S.K., Aggarwal A.K., Maas R., Rose D.W., Rosenfeld M.G.;
Nature 427:265-265(2004).
[11]
FUNCTION, AND DEVELOPMENTAL STAGE.
PubMed=14695375; DOI=10.1242/dev.00943;
Ozaki H., Nakamura K., Funahashi J., Ikeda K., Yamada G., Tokano H.,
Okamura H.O., Kitamura K., Muto S., Kotaki H., Sudo K., Horai R.,
Iwakura Y., Kawakami K.;
"Six1 controls patterning of the mouse otic vesicle.";
Development 131:551-562(2004).
[12]
FUNCTION.
PubMed=16488997; DOI=10.1158/0008-5472.CAN-05-2360;
Yu Y., Davicioni E., Triche T.J., Merlino G.;
"The homeoprotein six1 transcriptionally activates multiple
protumorigenic genes but requires ezrin to promote metastasis.";
Cancer Res. 66:1982-1989(2006).
[13]
DISRUPTION PHENOTYPE.
PubMed=21884692; DOI=10.1016/j.ydbio.2011.08.010;
Richard A.F., Demignon J., Sakakibara I., Pujol J., Favier M.,
Strochlic L., Le Grand F., Sgarioto N., Guernec A., Schmitt A.,
Cagnard N., Huang R., Legay C., Guillet-Deniau I., Maire P.;
"Genesis of muscle fiber-type diversity during mouse embryogenesis
relies on Six1 and Six4 gene expression.";
Dev. Biol. 359:303-320(2011).
-!- FUNCTION: Transcription factor that is involved in the regulation
of cell proliferation, apoptosis and embryonic development. Plays
an important role in the development of several organs, including
kidney, muscle and inner ear. Depending on context, functions as
transcriptional repressor or activator. Lacks an activation
domain, and requires interaction with EYA family members for
transcription activation. Mediates nuclear translocation of EYA1
and EYA2. Binds the 5'-TCA[AG][AG]TTNC-3' motif present in the
MEF3 element in the MYOG promoter. Regulates the expression of
numerous genes, including MYC, CCNA1, CCND1 and EZR. Acts as
activator of the IGFBP5 promoter, probably coactivated by EYA2.
Repression of precursor cell proliferation in myoblasts is
switched to activation through recruitment of EYA3 to the SIX1-
DACH1 complex. During myogenesis, seems to act together with EYA2
and DACH2. {ECO:0000269|PubMed:11978764,
ECO:0000269|PubMed:12215533, ECO:0000269|PubMed:12668636,
ECO:0000269|PubMed:12783782, ECO:0000269|PubMed:12834866,
ECO:0000269|PubMed:14628042, ECO:0000269|PubMed:14695375,
ECO:0000269|PubMed:16488997}.
-!- SUBUNIT: Interacts with EYA1. Interacts with CDC20 (By
similarity). Interacts with DACH1, EYA2 and EYA3. Interacts with
TBX18 (By similarity). {ECO:0000250|UniProtKB:Q15475,
ECO:0000269|PubMed:11978764, ECO:0000269|PubMed:12215533,
ECO:0000269|PubMed:14628042}.
-!- INTERACTION:
P97767:Eya1; NbExp=3; IntAct=EBI-1368483, EBI-1368503;
-!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15475}.
Cytoplasm {ECO:0000250|UniProtKB:Q15475}.
-!- TISSUE SPECIFICITY: Expressed in phalangeal tendons and in
skeletal muscle and in head and body mesenchyme.
-!- DEVELOPMENTAL STAGE: First expressed at E8.2-8.5 of embryo
development in the anterior head mesoderm and developing
pharyngeal pouches. Expression in the developing limb begins at
E11 and is more pronounced dorsally. It progresses into the
developing phalanges at E13.5. In the developing inner ear
detected in the otic placode and the surrounding surface ectoderm
at E8.5. Expression became prominent at the invaginating otic pit
and the nascent otic vesicle at E9.5. At E10.5, expression was
limited to the ventral half of the otic vesicle. Subsequently, the
expression became gradually restricted to the cochlear region at
E11.5 and E12.5. At later stages detected exclusively in the
cochlea at E14.5, and the expression in the cochlear duct
persisted in the neonate. In the developing kidney, is expressed
in the uninduced metanephric mesenchyme at E10.5 and in the
induced mesenchyme around the ureteric bud at E11.5. At E17.5 to
P0, expression becomes restricted to a subpopulation of collecting
tubule epithelial cells. {ECO:0000269|PubMed:12783782,
ECO:0000269|PubMed:14695375}.
-!- PTM: Phosphorylated during interphase; becomes hyperphosphorylated
during mitosis. Hyperphosphorylation impairs binding to promoter
elements (By similarity). {ECO:0000250}.
-!- PTM: Ubiquitinated by the anaphase promoting complex (APC),
leading to its proteasomal degradation. {ECO:0000250}.
-!- DISRUPTION PHENOTYPE: Perinatal lethality. Mice show failure in
renal organogenesis, a severe reduction of most migratory hypaxial
muscles including those of the forelimb, diaphragm and tongue, and
severe rib-cage deformation. Besides, mice display craniofacial
defects, including loss of inner ear structures. Pax2, Six2 and
Sall1 expression is markedly reduced in the metanephric mesenchyme
at E10.5 during kidney development. Mice lacking both Six1 and
Eya1 show defects in kidney development, complete absence of
hypaxial muscle, severe reduction in epaxial muscle and a 5-10-
fold by volume smaller pituarity than the wild-type gland.
{ECO:0000269|PubMed:12668636, ECO:0000269|PubMed:12783782,
ECO:0000269|PubMed:12834866, ECO:0000269|PubMed:14628042,
ECO:0000269|PubMed:21884692}.
-!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; X80339; CAA56585.1; -; mRNA.
EMBL; BC023304; AAH23304.1; -; mRNA.
CCDS; CCDS25973.1; -.
PIR; S60751; S60751.
RefSeq; NP_033215.2; NM_009189.3.
UniGene; Mm.4645; -.
ProteinModelPortal; Q62231; -.
SMR; Q62231; -.
BioGrid; 203259; 10.
CORUM; Q62231; -.
IntAct; Q62231; 1.
STRING; 10090.ENSMUSP00000059026; -.
PhosphoSitePlus; Q62231; -.
PaxDb; Q62231; -.
PRIDE; Q62231; -.
Ensembl; ENSMUST00000050029; ENSMUSP00000059026; ENSMUSG00000051367.
GeneID; 20471; -.
KEGG; mmu:20471; -.
UCSC; uc007nwa.2; mouse.
CTD; 6495; -.
MGI; MGI:102780; Six1.
eggNOG; KOG0775; Eukaryota.
eggNOG; ENOG410XRPB; LUCA.
GeneTree; ENSGT00540000070251; -.
HOGENOM; HOG000261680; -.
HOVERGEN; HBG003609; -.
InParanoid; Q62231; -.
KO; K15614; -.
OMA; AGGNKQN; -.
OrthoDB; EOG091G083I; -.
PhylomeDB; Q62231; -.
TreeFam; TF315545; -.
PRO; PR:Q62231; -.
Proteomes; UP000000589; Chromosome 12.
Bgee; ENSMUSG00000051367; -.
ExpressionAtlas; Q62231; baseline and differential.
Genevisible; Q62231; MM.
GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
GO; GO:0005730; C:nucleolus; ISO:MGI.
GO; GO:0005634; C:nucleus; IDA:MGI.
GO; GO:0005667; C:transcription factor complex; IDA:MGI.
GO; GO:0003682; F:chromatin binding; IGI:MGI.
GO; GO:0003677; F:DNA binding; ISO:MGI.
GO; GO:0003700; F:DNA binding transcription factor activity; IDA:MGI.
GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; ISO:MGI.
GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
GO; GO:0001223; F:transcription coactivator binding; IEA:Ensembl.
GO; GO:0044212; F:transcription regulatory region DNA binding; ISO:MGI.
GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; ISO:MGI.
GO; GO:0048856; P:anatomical structure development; IGI:MGI.
GO; GO:0035909; P:aorta morphogenesis; IGI:MGI.
GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IGI:MGI.
GO; GO:0008283; P:cell proliferation; IEA:InterPro.
GO; GO:1905243; P:cellular response to 3,3',5-triiodo-L-thyronine; IEA:Ensembl.
GO; GO:0090103; P:cochlea morphogenesis; IMP:MGI.
GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IGI:MGI.
GO; GO:0048704; P:embryonic skeletal system morphogenesis; IGI:MGI.
GO; GO:0030855; P:epithelial cell differentiation; IMP:MGI.
GO; GO:0021610; P:facial nerve morphogenesis; IMP:MGI.
GO; GO:0061197; P:fungiform papilla morphogenesis; IMP:UniProtKB.
GO; GO:0048699; P:generation of neurons; IMP:UniProtKB.
GO; GO:0048839; P:inner ear development; IMP:UniProtKB.
GO; GO:0042472; P:inner ear morphogenesis; IGI:MGI.
GO; GO:0001822; P:kidney development; IMP:UniProtKB.
GO; GO:0072172; P:mesonephric tubule formation; IMP:UniProtKB.
GO; GO:0072075; P:metanephric mesenchyme development; IMP:UniProtKB.
GO; GO:0042474; P:middle ear morphogenesis; IMP:MGI.
GO; GO:0051451; P:myoblast migration; IGI:MGI.
GO; GO:0061055; P:myotome development; IMP:UniProtKB.
GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
GO; GO:0090191; P:negative regulation of branching involved in ureteric bud morphogenesis; IMP:MGI.
GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI.
GO; GO:0022008; P:neurogenesis; IMP:UniProtKB.
GO; GO:0048665; P:neuron fate specification; IGI:MGI.
GO; GO:0030910; P:olfactory placode formation; IMP:UniProtKB.
GO; GO:0001759; P:organ induction; IMP:MGI.
GO; GO:0071599; P:otic vesicle development; IMP:MGI.
GO; GO:0003151; P:outflow tract morphogenesis; IGI:MGI.
GO; GO:0007389; P:pattern specification process; IMP:MGI.
GO; GO:0060037; P:pharyngeal system development; IMP:UniProtKB.
GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; IMP:UniProtKB.
GO; GO:2000729; P:positive regulation of mesenchymal cell proliferation involved in ureter development; IGI:MGI.
GO; GO:0072513; P:positive regulation of secondary heart field cardioblast proliferation; IGI:MGI.
GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.
GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
GO; GO:0072107; P:positive regulation of ureteric bud formation; IMP:UniProtKB.
GO; GO:0034504; P:protein localization to nucleus; ISO:MGI.
GO; GO:0072095; P:regulation of branch elongation involved in ureteric bud branching; IMP:UniProtKB.
GO; GO:0050678; P:regulation of epithelial cell proliferation; IMP:UniProtKB.
GO; GO:0010468; P:regulation of gene expression; IGI:MGI.
GO; GO:0045664; P:regulation of neuron differentiation; IMP:MGI.
GO; GO:0032880; P:regulation of protein localization; IGI:MGI.
GO; GO:2001014; P:regulation of skeletal muscle cell differentiation; IDA:UniProtKB.
GO; GO:0014842; P:regulation of skeletal muscle satellite cell proliferation; IDA:UniProtKB.
GO; GO:0008582; P:regulation of synaptic growth at neuromuscular junction; IGI:MGI.
GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI.
GO; GO:0072001; P:renal system development; IGI:MGI.
GO; GO:0007605; P:sensory perception of sound; IMP:MGI.
GO; GO:0007519; P:skeletal muscle tissue development; IMP:UniProtKB.
GO; GO:0048705; P:skeletal system morphogenesis; IMP:MGI.
GO; GO:0048538; P:thymus development; IMP:MGI.
GO; GO:0030878; P:thyroid gland development; IMP:MGI.
GO; GO:0043586; P:tongue development; IMP:UniProtKB.
GO; GO:0061551; P:trigeminal ganglion development; IMP:UniProtKB.
GO; GO:0072193; P:ureter smooth muscle cell differentiation; IMP:MGI.
GO; GO:0001657; P:ureteric bud development; IMP:MGI.
CDD; cd00086; homeodomain; 1.
InterPro; IPR009057; Homeobox-like_sf.
InterPro; IPR017970; Homeobox_CS.
InterPro; IPR001356; Homeobox_dom.
InterPro; IPR031278; SIX1.
InterPro; IPR031701; SIX1_SD.
PANTHER; PTHR10390:SF13; PTHR10390:SF13; 1.
Pfam; PF00046; Homeobox; 1.
Pfam; PF16878; SIX1_SD; 1.
SMART; SM00389; HOX; 1.
SUPFAM; SSF46689; SSF46689; 1.
PROSITE; PS00027; HOMEOBOX_1; 1.
PROSITE; PS50071; HOMEOBOX_2; 1.
1: Evidence at protein level;
Activator; Apoptosis; Complete proteome; Cytoplasm;
Developmental protein; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
Reference proteome; Repressor; Transcription;
Transcription regulation; Ubl conjugation.
CHAIN 1 284 Homeobox protein SIX1.
/FTId=PRO_0000049296.
DNA_BIND 124 183 Homeobox. {ECO:0000255|PROSITE-
ProRule:PRU00108}.
CONFLICT 12 14 EQV -> GQG (in Ref. 1; CAA56585).
{ECO:0000305}.
SEQUENCE 284 AA; 32210 MW; 4A6F88000FB9F8EB CRC64;
MSMLPSFGFT QEQVACVCEV LQQGGNLERL GRFLWSLPAC DHLHKNESVL KAKAVVAFHR
GNFRELYKIL ESHQFSPHNH PKLQQLWLKA HYVEAEKLRG RPLGAVGKYR VRRKFPLPRT
IWDGEETSYC FKEKSRGVLR EWYAHNPYPS PREKRELAEA TGLTTTQVSN WFKNRRQRDR
AAEAKERENT ENNNSSSNKQ NQLSPLEGGK PLMSSSEEEF SPPQSPDQNS VLLLQSNMGH
ARSSNYSLPG LTASQPSHGL QAHQHQLQDS LLGPLTSSLV DLGS


Related products :

Catalog number Product name Quantity
EIAAB38524 Homeobox protein SIX1,Homo sapiens,Human,Sine oculis homeobox homolog 1,SIX1
EIAAB38525 Homeobox protein SIX1,Mouse,Mus musculus,Sine oculis homeobox homolog 1,Six1
18-003-42195 Homeobox protein SIX6 - Sine oculis homeobox homolog 6; Optic homeobox 2; Homeodomain protein OPTX2 Polyclonal 0.05 mg Aff Pur
EIAAB38535 Homeobox protein SIX6,Homeodomain protein OPTX2,Homo sapiens,Human,Optic homeobox 2,OPTX2,Sine oculis homeobox homolog 6,SIX6,SIX9
EIAAB38536 Homeobox protein SIX6,Mouse,Mus musculus,Optic homeobox 2,Optx2,Sine oculis homeobox homolog 6,Six6,Six9,Six9 protein
EIAAB38527 Homeobox protein SIX2,Homo sapiens,Human,Sine oculis homeobox homolog 2,SIX2
EIAAB38530 Homeobox protein SIX3,Homo sapiens,Human,Sine oculis homeobox homolog 3,SIX3
EIAAB38531 Homeobox protein SIX4,Homo sapiens,Human,Sine oculis homeobox homolog 4,SIX4
EIAAB38526 Homeobox protein SIX2,Mouse,Mus musculus,Sine oculis homeobox homolog 2,Six2
EIAAB38528 Homeobox protein SIX3,Mouse,Mus musculus,Sine oculis homeobox homolog 3,Six3
EIAAB38533 DM locus-associated homeodomain protein homolog,Dmahp,Homeobox protein SIX5,Mouse,Mus musculus,Sine oculis homeobox homolog 5,Six5
EIAAB38534 DM locus-associated homeodomain protein,DMAHP,Homeobox protein SIX5,Homo sapiens,Human,Sine oculis homeobox homolog 5,SIX5
EIAAB38537 Chicken,Gallus gallus,Homeobox protein SIX6,Optic homeobox 2,OPTX2,Sine oculis homeobox homolog 6,SIX6,SIX9,Six9 protein
EIAAB38529 Chicken,CSIX3,Gallus gallus,Homeobox protein SIX3,Sine oculis homeobox homolog 3,SIX3
25-063 SIX1 is a homeobox protein that is similar to the Drosophila 'sine oculis' gene product. This gene is found in a cluster of related genes on chromosome 14 and is thought to be involved in limb develop 0.05 mg
EIAAB38532 Arec3,Homeobox protein SIX4,Mouse,Mus musculus,Sine oculis homeobox homolog 4,Six4,Skeletal muscle-specific ARE-binding protein AREC3
GWB-DC04F7 Anti- SIX6 (sine oculis homeobox homolog 6 (Drosophila)) Antibody
25-488 This gene is a member of the vertebrate gene family which encode proteins homologous to the Drosophila 'sine oculis' homeobox protein. SIX2 is a transcription factor which, like other members of this 0.05 mg
EIAAB27309 Cardiac-specific homeobox,Csx,Homeobox protein CSX,Homeobox protein NK-2 homolog E,Homeobox protein Nkx-2.5,Mouse,Mus musculus,Nkx-2.5,Nkx2-5,Nkx2e
EIAAB27320 Bagpipe homeobox protein homolog 1,BAPX1,Homeobox protein NK-3 homolog B,Homeobox protein Nkx-3.2,Homo sapiens,Human,NKX3-2,NKX3B
EIAAB27319 Bagpipe homeobox protein homolog 1,Bapx1,Homeobox protein NK-3 homolog B,Homeobox protein Nkx-3.2,Mouse,Mus musculus,Nkx-3.2,Nkx3-2,Nkx3b
EIAAB27310 Cardiac-specific homeobox,CSX,Homeobox protein CSX,Homeobox protein NK-2 homolog E,Homeobox protein Nkx-2.5,Homo sapiens,Human,NKX2.5,NKX2-5,NKX2E
SIX1_MOUSE ELISA Kit FOR Homeobox protein SIX1; organism: Mouse; gene name: Six1 96T
CSB-EL021348MO Mouse Homeobox protein SIX1(SIX1) ELISA kit SpeciesMouse 96T
CSB-EL021348HU Human Homeobox protein SIX1(SIX1) ELISA kit SpeciesHuman 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur